Module 3.3: Consume Probiotic Foods

Probiotics are defined as live microorganisms which confer a health benefit to the host, and they are what largely compose the GM (21). Probiotic consumption is a way to directly improve the composition of the gut microbiome by simply increasing the number of microorganisms that perform vital beneficial functions relating to physiology and immunology. Probiotic microorganisms regulate the Tight Junction proteins that regulate intestinal permeability, which has a direct impact on the immune system, and thus inflammation (2,3,4,5,12). Probiotic therapy is known to improve the GM and increase rates of remission in patients with IBD.

A double-blind study published in the Korean Journal of Gastroenterology tested the effects that probiotic yogurt consumption had on the GM of IBD patients. 105 patients with IBD and 95 healthy individuals were given 250 g of probiotic yogurt per day for 8 weeks, while another 105 patients with IBD were given 250 g of placebo per day for 8 weeks. The results of the study revealed that IBD patients receiving the probiotic yogurt had a significant increase in Lactobacillus and Bifidobacterium, well known probiotic bacteria, and a slight decrease in Bacteroides, which are bacteria that become pathogenic in certain circumstances (22,23). It’s important to know that even patients with IBD will see an increase in probiotic microorganisms within the GM if they consume probiotics. It’s important because it’s known that probiotic microorganisms, specifically Lactobacillus and Bifidobacterium, are able to decrease pathogenic microorganisms by competitive exclusion (12).

This means that, even in patients with IBD, probiotic therapy improves the GM composition by directly increasing probiotic microorganisms which can then begin to competitively exclude, and thus decrease, pathogenic microorganisms over time.

Not only do probiotics improve the GM, they increase rates of remission. A meta-analysis of 23 randomized controlled trials with a total of 1763 participants found that patients with active UC treated with probiotics had significantly higher rates of remission than UC patients treated with placebo (24).

Bottom line, probiotic therapy is known to improve the GM and increase IBD remission rates. So we definitely want to consume probiotics, however, introducing probiotics can be tricky initially because they can cause what’s known as the Jarisch-Herxheimer reaction. The Herxheimer reaction can occur when some sort of microbiological agent, such as antibiotics, antimicrobials, or probiotics, begins to kill pathogenic microorganisms (25,26). When these pathogenic microorganisms die, their cells burst open, which allows their toxic contents to be released into our bodies, which then triggers an inflammatory response from our immune system (26). For IBD patients, the symptoms most commonly experienced on an anecdotal basis as a result of the Herxheimer reaction are increases in the already present or normal IBD symptoms such as diarrhea, frequency, urgency, bleeding, gas, mucus, etc.

So this leaves us with two questions. Number one, why would we want to consume probiotics if they might induce the herxheimer reaction and cause symptoms to flare up or worsen? The reason we want to consume the probiotics is because we have to target the dysbiosis or imbalance in the gut microbiome. We need to establish a new level of homeostasis, aka eubiosis, in the GM where the probiotics are back in control so that they can perform all of their necessary functions that keep our bodies and digestive systems healthy. Question number two, how can we approach the introduction of probiotics so that we hopefully avoid a severe herxheimer reaction? Start low and slow. Starting out with a high volume of probiotics in the form of food or supplements could cause a significant amount of pathogenic microorganisms to die-off in a short amount of time, leading to a significant inflammatory response and increase in symptoms. But, if we start with a low amount of probiotic foods and supplements, that should theoretically cause a lower amount of pathogens to die-off at a slower rate, and thus lessen the intensity of the inflammatory immune response. This will allow us to slowly increase the volume of probiotic foods and supplements each week, as long as the Herxheimer reaction symptoms are not severe, until we are able to tolerably consume a high enough amount of probiotics each day that will correct the dysbiosis within the GM and bring it back to eubiosis.

This is often a game of give and take where each individual has to increase and decrease probiotic consumption based on the fluctuation of symptoms. The exact philosophy that I recommend using in order to do this will be explained in Module 5 before you are able to access the daily routines. Probiotics are very important, but it is also very important how they are implemented. That being said, here are my favorite sources of probiotic foods and supplements:

  1. Milk Kefir → Homemade Kefir | Rebuild Your Gut Microbiome
  2. Lacto-Fermented Vegetables → How to Make Fermented Vegetables | Rebuild Your Gut Microbiome
  3. Coconut milk kefir
  4. Coconut milk yogurt
  5. Supplements

‍

Biome Optima™ Sources

  1. Jandhyala SM, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Nageshwar Reddy D. Role of the normal gut microbiota. World J Gastroenterol. 2015;21(29):8787–8803.doi:10.3748/wjg.v21.i29.8787
  2. Bernstein CN, Forbes JD. Gut Microbiome in Inflammatory Bowel Disease and Other Chronic Immune-Mediated Inflammatory Diseases. Inflamm Intest Dis. 2017;2(2):116–123. doi:10.1159/000481401
  3. Yu LC. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis. J Biomed Sci. 2018;25(1):79. Published 2018 Nov 9. doi:10.1186/s12929-018-0483-8
  4. Suzuki T. Regulation of intestinal epithelial permeability by tight junctions. Cellular and Molecular Life Sciences. 2013; 70(4): 631-659.
  5. Ulluwishewa D, Anderson R, McNabb W, Moughan P, Wells J, Roy N. Regulation of Tight Junction Permeability by Intestinal Bacteria and Dietary Components. The Journal of Nutrition. 2011; 141(5): 769-776.
  6. Han X, Lee A, Huang S, Gao J, Spence JR, Owyang C. Lactobacillus rhamnosus GG prevents epithelial barrier dysfunction induced by interferon-gamma and fecal supernatants from irritable bowel syndrome patients in human intestinal enteroids and colonoids. Gut Microbes. 2019;10(1):59-76. doi:10.1080/19490976.2018.1479625
  7. Anderson RC, Cookson AL, McNabb WC, et al. Lactobacillus plantarum MB452 enhances the function of the intestinal barrier by increasing the expression levels of genes involved in tight junction formation. BMC Microbiol. 2010;10:316. Published 2010 Dec 9. doi:10.1186/1471-2180-10-316
  8. Klement RJ, Pazienza V. Impact of Different Types of Diet on Gut Microbiota Profiles and Cancer Prevention and Treatment. Medicina (Kaunas). 2019;55(4):84. Published 2019 Mar 29. doi:10.3390/medicina55040084
  9. Hsieh CY, Osaka T, Moriyama E, Date Y, Kikuchi J, Tsuneda S. Strengthening of the intestinal epithelial tight junction by Bifidobacterium bifidum. Physiol Rep. 2015;3(3):e12327. doi:10.14814/phy2.12327
  10. Zhang M, Sun K, Wu Y, Yang Y, Tso P, Wu Z. Interactions between Intestinal Microbiota and Host Immune Response in Inflammatory Bowel Disease. Front Immunol. 2017;8:942. Published 2017 Aug 14. doi:10.3389/fimmu.2017.00942
  11. La Fata G, Weber P, Mohajeri MH. Probiotics and the Gut Immune System: Indirect Regulation. Probiotics Antimicrob Proteins. 2018;10(1):11-21. doi:10.1007/s12602-017-9322-6
  12. Rao RK, Samak G. Protection and Restitution of Gut Barrier by Probiotics: Nutritional and Clinical Implications. Curr Nutr Food Sci. 2013;9(2):99–107. doi:10.2174/1573401311309020004.
  13. Martino D. The Effects of Chlorinated Drinking Water on the Assembly of the Intestinal Microbiome. Challenges. 2019; 10(1):10.
  14. Holscher HD. Dietary fiber and prebiotics and the gastrointestinal microbiota. Gut Microbes. 2017;8(2):172-184. doi:10.1080/19490976.2017.1290756
  15. Vandeputte D, Falony G, Vieira-Silva S, et al. Prebiotic inulin-type fructans induce specific changes in the human gut microbiota. Gut. 2017;66(11):1968-1974. doi:10.1136/gutjnl-2016-313271
  16. Maier TV, Lucio M, Lee LH, et al. Impact of Dietary Resistant Starch on the Human Gut Microbiome, Metaproteome, and Metabolome. mBio. 2017;8(5):e01343-17. Published 2017 Oct 17. doi:10.1128/mBio.01343-17
  17. Pituch-Zdanowska A, Banaszkiewicz A, Albrecht P. The role of dietary fibre in inflammatory bowel disease. Prz Gastroenterol. 2015;10(3):135-141. doi:10.5114/pg.2015.52753
  18. Kumari R, Ahuja V, Paul J. Fluctuations in butyrate-producing bacteria in ulcerative colitis patients of North India. World J Gastroenterol. 2013;19(22):3404-3414. doi:10.3748/wjg.v19.i22.3404
  19. McDonald D, Hyde E, Debelius JW, et al. American Gut: an Open Platform for Citizen Science Microbiome Research. mSystems. 2018;3(3):e00031-18. Published 2018 May 15. doi:10.1128/mSystems.00031-18
  20. Lambeau KV, McRorie JW Jr. Fiber supplements and clinically proven health benefits: How to recognize and recommend an effective fiber therapy. J Am Assoc Nurse Pract. 2017;29(4):216-223. doi:10.1002/2327-6924.12447.
  21. Shi LH, Balakrishnan K, Thiagarajah K, Mohd Ismail NI, Yin OS. Beneficial Properties of Probiotics. Trop Life Sci Res. 2016;27(2):73-90. doi:10.21315/tlsr2016.27.2.6
  22. Shadnoush M, Hosseini RS, Khalilnezhad A, Navai L, Goudarzi H, Vaezjalali M. Effects of Probiotics on Gut Microbiota in Patients with Inflammatory Bowel Disease: A Double-blind, Placebo-controlled Clinical Trial. Korean J Gastroenterol. 2015 Apr;65(4):215-21. doi: 10.4166/kjg.2015.65.4.215. PMID: 25896155.
  23. Wexler HM. Bacteroides: the good, the bad, and the nitty-gritty. Clin Microbiol Rev. 2007;20(4):593-621. doi:10.1128/CMR.00008-07.
  24. Shen J, Zuo ZX, Mao AP. Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: meta-analysis of randomized controlled trials. Inflamm Bowel Dis. 2014 Jan;20(1):21-35. doi: 10.1097/01.MIB.0000437495.30052.be. Erratum in: Inflamm Bowel Dis. 2014 Dec;20(12):2526-8. PMID: 24280877.
  25. Dhakal A, Sbar E. Jarisch Herxheimer Reaction. 2020 Nov 10. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan–. PMID: 32491752.
  26. Muscianese M, Magri F, Pranteda G, Pranteda G. A case of Jarisch-Herxheimer reaction in candidiasis treated with systemic fluconazole. Dermatol Ther. 2020 Mar;33(2):e13244. doi: 10.1111/dth.13244. Epub 2020 Feb 17. PMID: 32020750.

‍